These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 700003)

  • 1. Short-term increase and long-term reversion of striatal cell activity after degeneration of the nigrostriatal dopamine system.
    Schultz W; Ungerstedt U
    Exp Brain Res; 1978 Oct; 33(2):159-71. PubMed ID: 700003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Synapse; 1990; 5(2):83-93. PubMed ID: 2309160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study.
    Savasta M; Mennicken F; Chritin M; Abrous DN; Feuerstein C; Le Moal M; Herman JP
    Neuroscience; 1992; 46(3):729-38. PubMed ID: 1532053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies.
    Pollard H; Llorens C; Schwartz JC; Gros C; Dray F
    Brain Res; 1978 Aug; 151(2):392-8. PubMed ID: 209865
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological analysis of the functional ontogeny of the nigrostriatal dopaminergic neurons.
    Cheronis JC; Erinoff L; Heller A; Hoffmann PC
    Brain Res; 1979 Jun; 169(3):545-60. PubMed ID: 36209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous synaptic potentials in dopamine-denervated neostriatal neurons.
    Galarraga E; Bargas J; Martínez-Fong D; Aceves J
    Neurosci Lett; 1987 Oct; 81(3):351-5. PubMed ID: 3124024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
    Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.
    Javoy F; Sotelo C; Herbet A; Agid Y
    Brain Res; 1976 Feb; 102(2):201-15. PubMed ID: 1247882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of striatal neurons by dexamphetamine is antagonized by degeneration of striatal dopaminergic terminals.
    Warenycia MW; McKenzie GM
    J Neural Transm; 1987; 70(3-4):217-32. PubMed ID: 3119772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors.
    Porceddu ML; Giorgi O; De Montis G; Mele S; Cocco L; Ongini E; Biggio G
    Life Sci; 1987 Aug; 41(6):697-706. PubMed ID: 2956472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of cerebellectomy on ascending dopaminergic neurons in the rat brain.
    Lovell KL; Bruner CA; Moore KE
    Neurosci Lett; 1982 Oct; 32(2):187-92. PubMed ID: 7145238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons.
    Hollerman JR; Grace AA
    Brain Res; 1990 Nov; 533(2):203-12. PubMed ID: 2126975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase and aldehyde dehydrogenase activity in the striatum of rats after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Agid Y; Javoy F; Youdim MB
    Br J Pharmacol; 1973 May; 48(1):175-8. PubMed ID: 4724190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished responses of nigral dopaminergic neurons to haloperidol and morphine following lesions in the striatum.
    Kondo Y; Iwatsubo K
    Brain Res; 1980 Jan; 181(1):237-40. PubMed ID: 7350960
    [No Abstract]   [Full Text] [Related]  

  • 16. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.
    Hefti F; Melamed E; Wurtman RJ
    Brain Res; 1980 Aug; 195(1):123-37. PubMed ID: 6105003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions.
    Chen MT; Morales M; Woodward DJ; Hoffer BJ; Janak PH
    Exp Neurol; 2001 Sep; 171(1):72-83. PubMed ID: 11520122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome.
    Ungerstedt U
    Pharmacol Ther B; 1976; 2(1):37-40. PubMed ID: 772721
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in substantia nigra pars reticulata activity following lesions of the substantia nigra pars compacta.
    Sanderson P; Mavoungou R; Albe-Fessard D
    Neurosci Lett; 1986 Jun; 67(1):25-30. PubMed ID: 3014391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.